As culture conditions may lead to metabolic stresses that could alter RBC functionality, we first compared the metabolomes of cRets and nRets. nRets were purified from cord blood by supermagnetic microbead selection using a CD71 antibody 6 and were more than 96% ± 2% (n=5) pure. Reticulocytes metabolites were analyzed using two liquid chromatographic (LC) systems coupled to high resolution mass spectrometry operated in both negative and positive modes of electrospray ionization. 3, 7 The wide chemical diversity of metabolites is best assessed by this 3 optimal metabolomic approach that can detect highly polar metabolites such as sugar derivatives or amino acids using hydrophilic interaction LC, as well as fatty acids or acylcarnitines using reverse phase chromatography. Eighty-six metabolites of biological relevance were identified (Supplementary Table 1 ) and analyzed in nRets and cRets. We found that the concentration of metabolites related to glycolysis or glutathione metabolism, two important pathways of RBCs functions were similar in the two types of reticulocytes (Figure 1-2) . Twenty-one metabolites displayed at least a two fold increase or decrease in concentration in cRets compared to nRets ( Figure   1 ). Among the metabolites with increased concentration in cRets, six out of ten were amino acids (glutamine, alanine, serine, ornithine, threonine and asparagine) ( Figure   1 ). The increased concentration of these amino acids in the cRets is likely to be due to their high concentration in the culture media used and to the presence of their transporters at the surface of reticulocytes. 8 Metabolites related to membrane integrity (carnitine, O-propanoyl-carnitine, acetyl-carnitine and R-butyryl-carnitine)
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The increasing need for red blood cells (RBCs) together with the lack of donors have made the in vitro production of RBCs a major medical challenge. 1 We have recently developed a method to produce mature RBCs in vitro, starting from bone marrow, peripheral blood, leukapheresis or cord blood-derived CD34 + cells. This method is based on a three-steps protocol using a serum-free medium supplemented with cytokines. 2 Here, we assess the quality of the RBCs produced in vitro using metabolomics, developed recently for RBC analysis 3 or reticulocytes. 4 We show that native reticulocytes (nRets) and culture-derived reticulocytes (cRets) exhibit very similar metabolomics signatures, 80% of their metabolites being expressed at similar levels. The homology is almost complete (90% of metabolites expressed at similar levels) when are compared RBCs produced from nRets and from cRets. As culture conditions may lead to metabolic stresses that could alter RBC functionality, we first compared the metabolomes of cRets and nRets. nRets were purified from cord blood by supermagnetic microbead selection using a CD71 antibody 6 and were more than 96% ± 2% (n=5) pure. Reticulocytes metabolites were analyzed using two liquid chromatographic (LC) systems coupled to high resolution mass spectrometry operated in both negative and positive modes of electrospray ionization. 3, 7 The wide chemical diversity of metabolites is best assessed by this 3 optimal metabolomic approach that can detect highly polar metabolites such as sugar derivatives or amino acids using hydrophilic interaction LC, as well as fatty acids or acylcarnitines using reverse phase chromatography. Eighty-six metabolites of biological relevance were identified (Supplementary Table 1 ) and analyzed in nRets and cRets. We found that the concentration of metabolites related to glycolysis or glutathione metabolism, two important pathways of RBCs functions were similar in the two types of reticulocytes (Figure 1-2) . Twenty-one metabolites displayed at least a two fold increase or decrease in concentration in cRets compared to nRets ( Figure   1 ). Among the metabolites with increased concentration in cRets, six out of ten were amino acids (glutamine, alanine, serine, ornithine, threonine and asparagine) ( Figure   1 ). The increased concentration of these amino acids in the cRets is likely to be due to their high concentration in the culture media used and to the presence of their transporters at the surface of reticulocytes. 8 Metabolites related to membrane integrity (carnitine, O-propanoyl-carnitine, acetyl-carnitine and R-butyryl-carnitine)
were all derived from carnitine and had a decreased concentration in cRets ( Figure   1 -2). RBCs from sickle cell patients 9 and from patients with overhydrated stomatocytosis 10 also have increased concentrations of carnitine and acetyl-carnitine. Table 2 Metabolomes of cRets from blood from 4 independent umbilical cords and nRets from 5 independent umbilical cords were analyzed by LC/MS followed by identification in the metabolite database. 5 A diagram of high-and low-expressed metabolites is shown. cRets data are expressed as log 2 fold relative to the average expression level in nRets for each metabolite. Metabolites expression was considered significantly different between cRets and nRets when log 2 R was above +2 or below -2 (black bars) and was considered identical when log 2 R was between 
Supplemental Methods

1-1 Biological material and sample preparation
Cultured red blood cells Umbilical Cord Blood (CB) from normal full-term deliveries were obtained with informed consent. Cord Blood CD34 + cells were isolated by supermagnetic microbead selection using Mini-MACS columns (Miltenyi Biotech, Bergisch Glodbach, Germany) (94 ± 3 % purity). The cells were cultured in erythroid differentiation medium (EDM) based on IMDM (Iscove modified Dulbecco's medium, Biochrom, Germany) supplemented with stabilized glutamine, 330 µg/mL human holo-transferrin (BBI solutions, Sittingbourne, UK), 10 µg/mL recombinant human insulin (FEF, Denmark), 2 IU/mL heparin Choay (Sanofi, France) and 5% solvent/detergent virus inactivated (S/D) plasma (Etablissement Français du Sang, France). The procedure comprised three steps. In the first step (day 0 to day 8), 10 4 /mL CD34 + cells were cultured in EDM in the presence of 100 ng/mL SCF (PeproTech, Neuilly-sur-Seine, France), 5 ng/mL IL-3 (PeproTech) and 3 IU/mL Epo (Eprex, Janssen-Cilag, Issy-les-Moulineaux, France). On day 4, one volume of cell culture was diluted in four volumes of fresh medium containing SCF, IL-3, Epo. In the second step (day 8 to day 11), the cells were resuspended at 10 5 /mL and seeded onto MS-5 at 2x10
4 cells/cm 2 in EDM supplemented with Epo. In the third step (day 11 to day 15), the non adherent cells were recovered, centrifuged, diluted in fresh medium not containing cytokines (the volume of culture medium was doubled at day 11 as compared to day 8). Cells were re-seeded onto stromal cells. The cultures were maintained at 37°C in 5% CO 2 in air.
Stromal cells
The murine MS-5 stromal cell line was expanded in αMEM medium containing ribonucleosides, deoxyribonucleosides, Glutamax (Life Technology) and 10% fetal calf serum (FCS). At confluence, adherent cells were collected after treatment of the cultures for 7-10 min with trypsin-EDTA 1X (Life Technology) at 37°C. The recovered cells (usually 10 6 /25cm 2 ) were washed and replated at 4000/cm 2 in αMEM medium supplemented with Glutamax and 10% FCS. Cultures were incubated at 37°C under 5% CO 2 and adherence was usually reached after one week.
Deleukocytation
The cell suspensions were purified by passage through a deleukocyting filter to eliminate the expelled nuclei and residual erythroblasts. The purity of the cRBC samples was 99.3 ± 0.2 % after filtration and the filtered suspensions were washed twice in PBS.
Maturation of native and cultured reticulocytes
To induce the maturation of the RETc, cells were washed, resuspended at 5-7x10 6 /ml in IMDM + 5% human AB plasma without cytokines and co-cultured on a new stromal layer. The culture supernatants were renewed twice a week. Cultures were maintained at 37°C under 5% CO 2 .
Reticulocyte separation Native reticulocytes were isolated from peripheral blood by an immunomagnetic method (Miltenyi Biotec). Briefly, the cells were incubated with anti-CD71 microbeads (Miltenyi Biotec) and the labeled cells were enriched on Mini-MACS columns. The reticulocyte content of the CD71-purified population was controlled by thiazole orange staining.
Flow cytometric analyses
Cells were labeled with unconjugated or fluorescein isothiocyanate (FITC) or phycoerythrin (PE)-conjugated antibodies. Anti-CD235 (glycophorin A) -PE, anti-CD71-PE or -FITC, anti-CD36-FITC and anti-CD34-PE antibodies (Beckman Coulter, Marseille, France) were used for phenotyping. Analyses were performed on CYAN ™ ADP flow cytometer (Beckman Coulter) using Summit software.
Reticulocyte count 3x10
5 cells were washed in PBS (pH 7.4) and incubated with 300 µL of Retic-count solution (Retic-count/Thiazole-Orange, BD Biosciences, Le Pont-de-Claix, France) for 30 min at room temperature. A negative control was carried out by incubating the cells with PBS alone.
Mitochondrial Membrane Potential
Resdietraethylbenzimidazolyl-carbocyanine iodide (JC-1) was used to measure the mitochondrial membrane potential. When this cationic dye accumulates into the mitochondrial membrane it forms aggregates leading to a shift in fluorescence from green to orange. Briefly, 5x10 5 cells were washed and resuspended at 10 6 /mL in prewarmed EDM, and then incubated at 37°C under 5% CO 2 for 15 min with 20 ng/mL JC-1 (Life Technologies) or without JC-1 (for negative control). Cells were generously washed twice in prewarmed PBS and immediately analyzed on a CYAN ™ ADP flow cytometer (Beckman Coulter) using Summit software (Excitation 488nm; Emission 530-590 nm).
Deformability measurements
The cell flexibility of cRBC and native reticulocytes was determined using a laser diffraction technique [LORCA (Laser-assisted Optical Rotational Cell Analyzer); R&R Mechanotrics, Hoor, The Netherlands] as extensively described previously 1 2 The cell deformability was expressed as elongation index (EI) which was recorded continuously at various shear stresses in the range 0.3-30 Pa. The EI value at 30 Pa was referred to as EI max .
Preparation of RBC lysates and metabolite extraction 10 9 packed native or cultured cells were pelleted and resuspended in qs 1ml Milli-Q water, and boiled for 3 minutes. After centrifugation at 1430g for 3 minutes at 4°C, the supernatant was ultrafiltered with centrifugal filter devices, molecular weight cutoff of 30 000 followed by 10 000 (Amicon Ultra-4 centrifugal filter devices) at 4000g for 20 minutes at 20°C. The final ultrafiltrates were divided into 4 aliquots and frozen at -80°C until mass spectrometry analysis. Before injection into the chromatographic system, the samples were dried under nitrogen. Two aliquots of each sample were diluted in 105µL H 2 O /External Standards mixture (ExS) in 105µL of H 2 O/ACN/ExS, 40/60/5 µl for HILIC analysis . A quality control sample (QC) was obtained by pooling RBC samples subsequently diluted ½, ¼ and ⅛. A QC sample was injected after each dilution series and after each 10 samples to assess signal repeatability and stability.
1-2/ Instrumentation and LC-MS acquisitions:
LC-MS analyses were performed using a Dionex Ultimate chromatographic system (Thermo Fisher Scientific, Courtaboeuf, France) coupled to an Exactive spectrometer (Thermo Fisher Scientific, Courtaboeuf, France) fitted with an electrospray source operated in the positive and negative ion modes. The software interface was Xcalibur (version 2.1) (Thermo Fisher Scientific, Courtaboeuf, france). The mass spectrometer was calibrated before each analysis in both ESI polarities using the manufacturer's predefined methods and recommended calibration mixture provided by the manufacturer (external calibration).
The ultra-high performance liquid chromatographic (UHPLC) separation was performed on a hypersil GOLD C 18 1.9µm, 2.1mm x 150mm column at 30°C (Thermo Fisher Scientific, les Ulis, France). Hydrophilic interaction liquid chromatographic separation (HILIC) was achieved on a Sequant ZICpHILIC 5µm, 2.1 x 150mm at 15°C (Merck, Darmstadt, Germany). All chromatographic systems were equipped with an on line prefilter (Thermo). Experimental settings for each LC/MS condition are described below.
The Exactive mass spectrometer was operated with capillary voltage at -3 kV in the negative ionization mode and 5 kV in the positive ionization and capillary temperature at 280°C. The sheath gas pressure and the auxiliary gas pressure were set, respectively, at 60 and 10 arbitrary units with nitrogen gas. The mass resolution power of the analyzer was set to 50000 m/Δm, full width at half maximum (FWHM) at 200u, for singly charged ions. The detection was achieved from 50 to 1000 u in the positive ionization mode, from 95 to 1000u for reverse phase (RP) chromatography in the negative ionization mode and from 85 to 1000u for HILIC conditions.
Mobile phases for UHPLC were 100% water in A and 100% ACN in B, both containing 0.1% formic acid. Regarding HILIC, phase A consisted of an aqueous buffer of 10mM of ammonium carbonate in water with ammonium hydroxide to adjust basicity to pH 10.5, whereas acetonitrile was used as solvent B. Chromatographic elutions were achieved under gradient conditions as follows: (i) RP based system: the flow rate was set at 500µL/min. The elution consisted of an isocratic step of 2 minutes at 5% phase B, followed by a linear gradient from 5 to 100% of phase B for the next 11 minutes. These proportions were kept constant for 12.5 min before returning to 5% B for 4.5 min.
(ii) HILIC based system: the flow rate was 200µL/min. Elution started with an isocratic step of 2 min at 80% B, followed by a linear gradient from 80 to 40% of phase B from 2 to 12 min. The chromatographic system was then rinsed for 5 min at 0% B, and the run ended with an equilibration step of 15 min. 2-4/ Data processing: All raw data were manually inspected using the Qualbrowser module of Xcalibur version 2.1 (Thermo Fisher Scientific, Courtaboeuf, France). Automatic peak detection and integration were performed using the XCMS software package. 3 Grouping of features was performed using CAMERA software. 4 Features were then annotated by matching their accurate measured mass at ± 10 ppm with theoretical ones contained in biochemical and metabolomic databases such as KEGG 5 HMDB 6 , Metlin 7 by using an informatics tool developed in R language, and also by our spectral database according to accurate measured masses and chromatographic retention times. 8, 9 Signal Drift Correction and Batch Effect Removal Within each peak table, intensities were corrected for signal drift and batch effect by fitting a locally quadratic (loess) regression model to the QC values.
10, 11 The α parameter controlling the smoothing was set to 1 to avoid overfitting. Once the peak tables were normalized, metabolites with a coefficient of variation (CV) of their QC values >25% were filtered out. Supplementary Figure 1 : In vitro production of RBCs from cord blood CD34 + : The method used comprises three steps. In the first step, CD34 + cells purified from Umbilical Cord Blood are grown for 8 days in medium supplemented with stem cell factor (SCF), interleukin-3 (IL-3) and erythropoietin (Epo). Then (second step), the cells are cultured on the murine MS-5 stromal cell line in the presence of Epo (day 8 to day 11). In the third step, all exogenous factors are withdrawn and the cells are grown further on MS-5 stromal cells without cytokines for up to 5 days. This protocol permits massive erythroid expansion and complete differentiation into mature cultured Red Blood Cells (cRBCs).
Supplemental Figures
Supplementary Figure 2: Deformability profiles of cultured reticulocytes before and after maturation:
Cultured reticulocytes (cRets) were recovered at day 15 of culture and purified using a deleukocyting filter. Culturing the purified cRets for 8 supplementary days set up a maturation step. The deformability (elongation index, EI) of the cRets (n=3) was evaluated on LORCA over a range of shear stresses (0.3-30 Pa) before (black curve) and after the maturation step (grey curve). 
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